FDA Week - 01/10/2020

AAM Appeals District Court Ruling In California Pay-For-Delay Case

By Beth Wang / January 6, 2020 at 3:49 PM
The generic drug lobby is appealing a California district court’s decision not to block the state’s pay-for-delay law, which went into effect Jan. 1. The group, which filed suit against the state in November, now seeks relief in the Ninth Circuit. The Association for Accessible Medicines argues the California law is unconstitutional and will harm patients by denying them earlier access to affordable generic and biosimilar medicines. Assembly bill 824 (AB 824), which California Gov. Gavin Newsom (D) signed into...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.